Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
City of Hope Medical Center
Thomas Jefferson University
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Affiliated People's Hospital of Ningbo University
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
University of California, Davis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
University of California, San Francisco
Northside Hospital, Inc.
M.D. Anderson Cancer Center
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center